Over the past 12 months, 0 insiders at Emmaus Life Sciences, Inc. filed 0 open-market SEC Form 4 transactions on EMMA: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 24 | Seah H. LimDirector | BUY | 20.0K | $0.04 | $800 |
| Feb 29, 24 | Willis C LeeCo-President & COO | BUY | 77.0K | $0.13 | $10K |
| Feb 28, 24 | Willis C LeeCo-President & COO | BUY | 15.0K | $0.12 | $2K |
| Feb 27, 24 | Willis C LeeCo-President & COO | BUY | 10.0K | $0.13 | $1K |
| Feb 26, 24 | Willis C LeeCo-President & COO | BUY | 13.2K | $0.12 | $2K |
| Dec 20, 23 | Seah H. LimDirector | SELL | 32.5K | $0.05 | $2K |
| Dec 15, 23 | Seah H. LimDirector | SELL | 6.0K | $0.11 | $660 |
| Nov 30, 23 | Willis C LeeCOO | BUY | 59.4K | $0.12 | $7K |
| Nov 29, 23 | Willis C LeeCOO | BUY | 36.0K | $0.12 | $4K |
| Nov 28, 23 | Willis C LeeCOO | BUY | 12.0K | $0.12 | $1K |
| Nov 14, 23 | Willis C LeeCOO | BUY | 1.1K | $0.12 | $132 |
| Sep 5, 23 | Seah H. LimDirector | BUY | 1.7K | $0.15 | $255 |
| Aug 31, 23 | Willis C LeeCOO | BUY | 6.0K | $0.15 | $900 |
| Aug 30, 23 | Seah H. LimDirector | BUY | 20.0K | $0.15 | $3K |
| Aug 25, 23 | Willis C LeeCOO | BUY | 6.5K | $0.21 | $1K |
| Aug 25, 23 | Seah H. LimDirector | BUY | 92.1K | $0.27 | $25K |
| May 31, 23 | Willis C LeeCOO | BUY | 28.7K | $0.29 | $8K |
| Nov 30, 22 | Yutaka NiiharaChairman and CEO | BUY | 22.9K | $0.41 | $9K |
| Nov 29, 22 | Yutaka NiiharaChairman and CEO | BUY | 14.7K | $0.38 | $6K |
| Nov 28, 22 | Yutaka NiiharaChairman and CEO | BUY | 5.0K | $0.35 | $2K |
| Nov 4, 22 | Yutaka NiiharaChairman and CEO | BUY | 7.5K | $0.45 | $3K |
| Nov 3, 22 | Yutaka NiiharaChairman and CEO | BUY | 2.5K | $0.45 | $1K |
| Nov 2, 22 | Yutaka NiiharaChairman and CEO | BUY | 15.0K | $0.43 | $6K |
| Nov 1, 22 | Yutaka NiiharaChairman and CEO | BUY | 5.0K | $0.43 | $2K |
| Oct 31, 22 | Yutaka NiiharaChairman and CEO | BUY | 7.5K | $0.45 | $3K |
| Oct 28, 22 | Yutaka NiiharaChairman and CEO | BUY | 7.5K | $0.42 | $3K |
| Oct 27, 22 | Yutaka NiiharaChairman and CEO | BUY | 22.5K | $0.27 | $6K |
| Oct 26, 22 | Yutaka NiiharaChairman and CEO | BUY | 11.9K | $0.27 | $3K |
| Oct 25, 22 | Yutaka NiiharaChairman and CEO | BUY | 20.0K | $0.26 | $5K |
| Oct 24, 22 | Yutaka NiiharaChairman and CEO | BUY | 7.5K | $0.22 | $2K |
| Oct 21, 22 | Yutaka NiiharaChairman and CEO | BUY | 10.0K | $0.19 | $2K |
| Oct 20, 22 | Yutaka NiiharaChairman and CEO | BUY | 30.0K | $0.18 | $5K |
| Oct 19, 22 | Yutaka NiiharaChairman and CEO | BUY | 25.0K | $0.16 | $4K |
| Oct 18, 22 | Yutaka NiiharaChairman and CEO | BUY | 30.0K | $0.19 | $6K |
| Oct 17, 22 | Yutaka NiiharaChairman and CEO | BUY | 15.0K | $0.20 | $3K |
| Oct 14, 22 | Yutaka NiiharaChairman and CEO | BUY | 35.0K | $0.17 | $6K |
| Oct 13, 22 | Yutaka NiiharaChairman and CEO | BUY | 62.5K | $0.18 | $11K |
| Oct 12, 22 | Yutaka NiiharaChairman and CEO | BUY | 160.0K | $0.08 | $13K |
| Oct 11, 22 | Yutaka NiiharaChairman and CEO | BUY | 130.0K | $0.09 | $12K |
| Oct 10, 22 | Yutaka NiiharaChairman and CEO | BUY | 10.0K | $0.09 | $900 |
| Oct 9, 22 | Seah H. LimDirector | BUY | 25.4K | $0.11 | $3K |
| Oct 7, 22 | Yutaka NiiharaChairman and CEO | BUY | 4.0K | $0.13 | $520 |
| Oct 6, 22 | Yutaka NiiharaChairman and CEO | BUY | 5.0K | $0.15 | $750 |
| Oct 5, 22 | Yutaka NiiharaChairman and CEO | BUY | 10.0K | $0.15 | $2K |
| Oct 4, 22 | Yutaka NiiharaChairman and CEO | BUY | 5.0K | $0.16 | $800 |
| Oct 3, 22 | Yutaka NiiharaChairman and CEO | BUY | 10.0K | $0.20 | $2K |
| Sep 27, 22 | Yutaka NiiharaChairman and CEO | BUY | 5.0K | $0.20 | $1K |
| Sep 26, 22 | Yutaka NiiharaChairman and CEO | BUY | 6.0K | $0.20 | $1K |
| Sep 20, 22 | Willis C LeeCOO | BUY | 750 | $0.28 | $210 |
| Jul 19, 22 | Willis C LeeCOO | BUY | 3.2K | $0.39 | $1K |
Over the past 12 months, insiders at Emmaus Life Sciences, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on EMMA, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market EMMA insider purchase in our data was $25K by Seah H. Lim, Director, filed on Aug 25, 23.
0 different insiders at Emmaus Life Sciences, Inc. filed open-market SEC Form 4 transactions on EMMA over the last 12 months.
InsiderTape plots every EMMA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Emmaus Life Sciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →